The global medical foods market size is expected to reach USD 38.9 billion by 2033, registering a CAGR of 6.0% from 2026 to 2033, according to a new report by Grand View Research, Inc. Rising geriatric population, prevalence of chronic diseases, a shift toward consuming disease-specific formulas, and a growing demand for neonatal and preterm enteral feeding are some of the factors driving this growth.
The oral route of the administration segment dominated the market in 2024. The major factors contributing to this growth include a high preference for oral medical foods owing to the ease of consumption and high commercial viability of products administered orally. In addition, these foods are available in a variety of forms such as pills, powder, puddings, and pre-thickened products, thereby fueling the segment’s growth.
In 2024, the powder product segment accounted for the largest revenue share. Factors contributing to the growth include the rising application areas of powdered medical foods, ease of administration, and higher commercial viability. The liquid segment is anticipated to grow at the fastest CAGR from 2025 to 2030, owing to the ease of consumption of liquid-based foods for special medical purposes by the pediatric and geriatric population.
The chemotherapy-induced diarrhea emerged as the largest application segment in 2024.. Diarrhea caused by chemotherapy treatment is one of the common problems among cancer patients and the rising prevalence of cancer is one of the major reasons for this increasing the revenue share. For instance, according to the National Cancer Institute statistics, about half of the patients develop diarrhea when treated with chemotherapy agents and the rate can reach 80% with respect to certain chemotherapy agents.
The institutional sales channel segment dominated the market in 2024. Higher penetration and adoption of oral and enteral medical foods in the healthcare institutions such as clinics, hospitals, and care centers and the rising consumption of these products are some of the major factors contributing to the large revenue share. In addition, the rising demand for such products in inpatient facilities and increasing adoption for such products are boosting the market growth.
North America dominated the market with a revenue share of approximately 30% in 2023.. The presence of major players and high revenue generated by them in the region are the key factors contributing to this growth. In addition, strategic developments, the growing prevalence of chronic conditions, and the increasing adoption of medical foods by patients and healthcare professionals are the other factors supporting the growth.
Request a free sample copy or view report summary: Medical Foods Market Report
Based on route of administration, the oral segment led the market with the largest revenue share in 2025, attributed to the increased preference for orally administered products, their commercial viability, and supportive healthcare initiatives promoting nutritional therapy.
Based on product, the powder segment led the market with the largest revenue share of 35.6% in 2025. Medical foods are most widely available in powder form, which can be administered through the oral route or enteral route by mixing milk or water, as advised by the physician.
Based on application, the cancer segment led the market with the largest revenue share of 12.2% in 2025. The high burden of cancer and the associated risk of malnutrition among patients are key factors driving demand for medical foods in oncology care
Based on module, the hypoallergenic module segment is expected to grow at a significant CAGR over the forecast period. Protein modules are used in severe infections, trauma, burns, malnutrition, post-surgery recovery, and critically ill patients.
Based on sales channel, the DTC segment led the market with the largest revenue share in 2025. This model has gained traction due to its ability to provide personalized customer experiences and foster brand loyalty.
North America dominated the medical foods market with the largest revenue share of 32.5% in 2025. Growth in the market can be attributed to the increasing geriatric population, which is more susceptible to chronic diseases, such as gastrointestinal disorders, metabolic disorders, and neurological disorders.
Grand View Research has segmented the global medical foods market based on route of administration, product, application, module, sales channel, and region:
Medical Foods Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
Oral
Enteral
Medical Foods Product Outlook (Revenue, USD Million, 2021 - 2033)
Powder
Pills
Liquid
Other
Medical Foods Application Outlook (Revenue, USD Million, 2021 - 2033)
Chronic Kidney Disease
Minimal Hepatic Encephalopathy
Chemotherapy-Induced Diarrhoea
Pathogen-Related Infections
Diabetic Neuropathy
ADHD
Depression
Alzheimer's Disease
Nutritional Deficiency
Orphan Diseases
Tyrosinemia
Eosinophilic Esophagitis
FPIES
Phenylketonuria
MSUD
Homocystinuria
Others
Wound Healing
Chronic Diarrhea
Constipation Relief
Protein Booster
Dysphagia
Pain Management
Parkinson's Disease
Epilepsy
Other Cancer-related treatments
Severe Protein Allergy
Cancer
Cachexia
Other
Medical Foods Module Outlook (Revenue, USD Million, 2021 - 2033)
Amino Acid Module
Protein Module
Vitamin & Mineral Modules
Fatty Acid-based Modules
Carbohydrate Modules
Fiber Modules
Ketogenic Modules
Peptide-based Modules
Hypoallergenic Modules
Others (Electrolyte Module, etc.)
Medical Foods Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
DTC Sales Channel
Online Sales
Retail Sales
Institutional Sales
Hospitals
Others (Long-term Care Facilities, etc.
Medical Foods Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S
Canada
Mexico
Europe
UK
Germany
Spain
France
Italy
Denmark
Sweden
Norway
Poland
Netherlands
Portugal
Slovakia
Finland
Czech Republic
Hungary
Belgium
Asia Pacific
Japan
China
Australia
India
South Korea
Thailand
Vietnam
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Kuwait
List Of Key Players Medical Foods Market
Danone
Nestlé
Abbott
Fresenius Kabi AG
Mead Johnson & Company, LLC
Hexagon Nutrition Ltd.
Biovencer Healthcare Pvt Ltd
Meiji Holdings. Co., Ltd.
Daisyfsmp (JIANGSU DAISY FSMP CO., LTD)
Ausnutria Dairy Corporation Ltd.
Maifu Nutrition Technology
Megalabs
"The quality of research they have done for us has been excellent..."